{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:55:40Z","timestamp":1791320140961,"version":"4.3.1"},"reference-count":255,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00702-021-02449-2","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T06:13:19Z","timestamp":1639721599000},"page":"1-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Recent update on the heterogeneity of the Alzheimer\u2019s disease spectrum"],"prefix":"10.1007","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"2449_CR1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3233\/JAD-171181","volume":"63","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Parchi P (2018a) Rapidly progressive Alzheimer\u2019s disease: contributions to clinical-pathological definition and diagnosis. J Alzheimers Dis 63:887\u2013897","journal-title":"J Alzheimers Dis"},{"key":"2449_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, Ladogana A, Parchi P (2018b) The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther 10:3","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s40478-021-01260-0","volume":"9","author":"S Agrawal","year":"2021","unstructured":"Agrawal S, Yu L, Nag S, Arfanakis K, Barnes LL, Bennett DA, Schneider JA (2021) The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer\u2019s dementia in older persons. Acta Neuropathol Commun 9:156","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/1389203722666210618110233","volume":"22","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Haque S, Chavda V, Ashraf GM (2021) Recent advances in synaptosomal proteomics in Alzheimer\u2019s disease. Curr Protein Pept Sci 22:479-492","journal-title":"Curr Protein Pept Sci"},{"key":"2449_CR5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp-2012-302798","volume":"83","author":"S Ahmed","year":"2012","unstructured":"Ahmed S, de Jager CA, Haigh AM, Garrard P (2012) Logopenic aphasia in Alzheimer\u2019s disease: clinical variant or clinical feature? J Neurol Neurosurg Psychiatry 83:1056\u20131062","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2449_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-200925","volume":"78","author":"I Alafuzoff","year":"2020","unstructured":"Alafuzoff I, Libard S (2020) Mixed brain pathology is the most common cause of cognitive impairment in the elderly. J Alzheimers Dis 78:453\u2013465","journal-title":"J Alzheimers Dis"},{"key":"2449_CR7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","volume":"18","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H (2008) Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium. Brain Pathol 18:484\u2013496","journal-title":"Brain Pathol"},{"key":"2449_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2012.03.004","volume":"34","author":"SE Arnold","year":"2013","unstructured":"Arnold SE, Louneva N, Cao K, Wang LS, Han LY, Wolk DA, Negash S, Leurgans SE, Schneider JA, Buchman AS, Wilson RS, Bennett DA (2013) Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer\u2019s disease. Neurobiol Aging 34:157\u2013168","journal-title":"Neurobiol Aging"},{"key":"2449_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"A Association","year":"2021","unstructured":"Alzheimer's Association (2021) 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 17:327\u2013406","journal-title":"Alzheimers Dement"},{"key":"2449_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, Polvikoski T, Sikorska B, Smith C, Grinberg LT, Thal DR, Trojanowski JQ, McKeith IG (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141:159\u2013172","journal-title":"Acta Neuropathol"},{"key":"2449_CR11","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/brain\/awz384","volume":"143","author":"A Badhwar","year":"2020","unstructured":"Badhwar A, McFall GP, Sapkota S, Black SE, Chertkow H, Duchesne S, Masellis M, Li L, Dixon RA, Bellec P (2020) A multiomics approach to heterogeneity in Alzheimer\u2019s disease: focused review and roadmap. Brain 143:1315\u20131331","journal-title":"Brain"},{"key":"2449_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004010050726","volume":"94","author":"C Bancher","year":"1997","unstructured":"Bancher C, Egensperger R, Kosel S, Jellinger K, Graeber MB (1997) Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol 94:403\u2013409","journal-title":"Acta Neuropathol"},{"key":"2449_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211050405","author":"H Barenholtz Levy","year":"2021","unstructured":"Barenholtz Levy H (2021) Accelerated approval of aducanumab: where do we stand now? Ann Pharmacother. https:\/\/doi.org\/10.1177\/10600280211050405","journal-title":"Ann Pharmacother"},{"key":"2449_CR14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-181285","volume":"69","author":"E Bayram","year":"2019","unstructured":"Bayram E, Shan G, Cummings JL (2019) Associations between comorbid TDP-43, Lewy body pathology, and neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis 69:953\u2013961","journal-title":"J Alzheimers Dis"},{"key":"2449_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-201213","volume":"79","author":"TG Beach","year":"2021","unstructured":"Beach TG, Malek-Ahmadi M (2021) Alzheimer's disease neuropathological comorbidities are common in the younger-old. J Alzheimers Dis 79:389\u2013400","journal-title":"J Alzheimers Dis"},{"key":"2449_CR16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000511210","volume":"49","author":"D Bergeron","year":"2020","unstructured":"Bergeron D, Sellami L, Poulin S, Verret L, Bouchard RW, Laforce R Jr (2020) The behavioral\/dysexecutive variant of Alzheimer\u2019s disease: a case series with clinical, neuropsychological, and FDG-PET characterization. Dement Geriatr Cogn Disord 49:518\u2013525","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2449_CR17","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/brain\/awab114","volume":"144","author":"D Berron","year":"2021","unstructured":"Berron D, Vogel JW, Insel PS, Pereira JB, Xie L, Wisse LEM, Yushkevich PA, Palmqvist S, Mattsson-Carlgren N, Stomrud E, Smith R, Strandberg O, Hansson O (2021) Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain 144:2771\u20132783","journal-title":"Brain"},{"key":"2449_CR18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nly049","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, Montine TJ, Schneider JA, Nelson PT (2018) The revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology form-available data and new analyses. J Neuropathol Exp Neurol 77:717\u2013726","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnen\/nlz126","volume":"79","author":"LM Besser","year":"2020","unstructured":"Besser LM, Teylan MA, Nelson PT (2020) Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations. J Neuropathol Exp Neurol 79:305\u2013313","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR20","doi-asserted-by":"publisher","unstructured":"Birkenbihl C, Salimi Y, Fr\u00f6hlich H (2021) Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12387","DOI":"10.1002\/alz.12387"},{"key":"2449_CR21","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/brain\/awab092","volume":"144","author":"PA Boyle","year":"2021","unstructured":"Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, Schneider JA, Bennett DA (2021) To what degree is late life cognitive decline driven by age-related neuropathologies? Brain 144:2166\u20132175","journal-title":"Brain"},{"key":"2449_CR22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2449_CR23","doi-asserted-by":"crossref","first-page":"e0142756","DOI":"10.1371\/journal.pone.0142756","volume":"10","author":"MS Byun","year":"2015","unstructured":"Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK, Choi HJ, Baek H, Han JY, Woo JI, Lee DY (2015) Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer\u2019s disease. PLoS ONE 10:e0142756","journal-title":"PLoS ONE"},{"key":"2449_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00401-011-0821-3","volume":"122","author":"MF Casanova","year":"2011","unstructured":"Casanova MF, Starkstein SE, Jellinger KA (2011) Clinicopathological correlates of behavioral and psychological symptoms of dementia. Acta Neuropathol 122:117\u2013135","journal-title":"Acta Neuropathol"},{"key":"2449_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000515322","volume":"20","author":"N Cedres","year":"2020","unstructured":"Cedres N, Ekman U, Poulakis K, Shams S, Cavallin L, Muehlboeck S, Granberg T, Wahlund LO, Ferreira D, Westman E (2020) Brain atrophy subtypes and the ATN classification scheme in Alzheimer\u2019s disease. Neurodegener Dis 20:153\u2013164","journal-title":"Neurodegener Dis"},{"key":"2449_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fneur.2012.00073","volume":"3","author":"J Cerejeira","year":"2012","unstructured":"Cerejeira J, Lagarto L, Mukaetova-Ladinska EB (2012) Behavioral and psychological symptoms of dementia. Front Neurol 3:73","journal-title":"Front Neurol"},{"key":"2449_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3233\/JAD-190264","volume":"71","author":"A Charil","year":"2019","unstructured":"Charil A, Shcherbinin S, Southekal S, Devous MD, Mintun M, Murray ME, Miller BB, Schwarz AJ (2019) Tau subtypes of Alzheimer\u2019s disease determined in vivo using flortaucipir PET imaging. J Alzheimers Dis 71:1037\u20131048","journal-title":"J Alzheimers Dis"},{"key":"2449_CR28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A (2020) Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol 19:951\u2013962","journal-title":"Lancet Neurol"},{"key":"2449_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","volume":"12","author":"M Colom-Cadena","year":"2020","unstructured":"Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alzheimers Res Ther 12:21","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR30","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1021\/acs.jpclett.1c02306","volume":"12","author":"MP Confer","year":"2021","unstructured":"Confer MP, Holcombe BM, Foes AG, Holmquist JM, Walker SC, Deb S, Ghosh A (2021) Label-free infrared spectroscopic imaging reveals heterogeneity of beta-sheet aggregates in Alzheimer's disease. J Phys Chem Lett 12:9662\u20139671","journal-title":"J Phys Chem Lett"},{"key":"2449_CR31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766","journal-title":"Acta Neuropathol"},{"key":"2449_CR32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","volume":"13","author":"SJ Crutch","year":"2017","unstructured":"Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suarez Gonzalez A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC (2017) Consensus classification of posterior cortical atrophy. Alzheimers Dement 13:870\u2013884","journal-title":"Alzheimers Dement"},{"key":"2449_CR33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ana.26233","volume":"90","author":"SR Das","year":"2021","unstructured":"Das SR, Lyu X, Duong MT, Xie L, McCollum L, de Flores R, DiCalogero M, Irwin DJ, Dickerson BC, Nasrallah IM, Yushkevich PA, Wolk DA (2021) Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer\u2019s disease. Ann Neurol 90:751\u2013762","journal-title":"Ann Neurol"},{"key":"2449_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14:32","journal-title":"Mol Neurodegener"},{"key":"2449_CR35","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/s41598-018-21641-1","volume":"8","author":"G Di Fede","year":"2018","unstructured":"Di Fede G, Catania M, Maderna E, Ghidoni R, Benussi L, Tonoli E, Giaccone G, Moda F, Paterlini A, Campagnani I, Sorrentino S, Colombo L, Kubis A, Bistaffa E, Ghetti B, Tagliavini F (2018) Molecular subtypes of Alzheimer\u2019s disease. Sci Rep 8:3269","journal-title":"Sci Rep"},{"key":"2449_CR36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jalz.2016.02.005","volume":"12","author":"F Di Stefano","year":"2016","unstructured":"Di Stefano F, Kas A, Habert MO, Decazes P, Lamari F, Lista S, Hampel H, Teichmann M (2016) The phenotypical core of Alzheimer\u2019s disease-related and nonrelated variants of the corticobasal syndrome: a systematic clinical, neuropsychological, imaging, and biomarker study. Alzheimers Dement 12:786\u2013795","journal-title":"Alzheimers Dement"},{"key":"2449_CR37","first-page":"735","volume":"140","author":"A Dong","year":"2017","unstructured":"Dong A, Toledo JB, Honnorat N, Doshi J, Varol E, Sotiras A, Wolk D, Trojanowski JQ, Davatzikos C (2017) Heterogeneity of neuroanatomical patterns in prodromal Alzheimer\u2019s disease: links to cognition, progression and biomarkers. Brain 140:735\u2013747","journal-title":"Brain"},{"key":"2449_CR38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3233\/JAD-160316","volume":"55","author":"J Dronse","year":"2017","unstructured":"Dronse J, Fliessbach K, Bischof GN, von Reutern B, Faber J, Hammes J, Kuhnert G, Neumaier B, Onur OA, Kukolja J, van Eimeren T, Jessen F, Fink GR, Klockgether T, Drzezga A (2017) In vivo patterns of tau pathology, amyloid-beta burden, and neuronal dysfunction in clinical variants of Alzheimer\u2019s disease. J Alzheimers Dis 55:465\u2013471","journal-title":"J Alzheimers Dis"},{"key":"2449_CR39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00401-017-1691-0","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, Shao Y, Safar JG, Ueberheide B, Wisniewski T (2017) Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer\u2019s disease. Acta Neuropathol 133:933\u2013954","journal-title":"Acta Neuropathol"},{"key":"2449_CR40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH (2021) Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol 20:484\u2013496","journal-title":"Lancet Neurol"},{"key":"2449_CR41","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat Med 26:1256\u20131263","journal-title":"Nat Med"},{"key":"2449_CR42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-021-01155-0","volume":"9","author":"C Duran-Aniotz","year":"2021","unstructured":"Duran-Aniotz C, Moreno-Gonzalez I, Gamez N, Perez-Urrutia N, Vegas-Gomez L, Soto C, Morales R (2021) Amyloid pathology arrangements in Alzheimer\u2019s disease brains modulate in vivo seeding capability. Acta Neuropathol Commun 9:56","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR43","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","volume":"129","author":"C Duyckaerts","year":"2015","unstructured":"Duyckaerts C, Braak H, Brion JP, Bu\u00e9e L, Del Tredici K, Goedert M, Halliday G, Neumann M, Spillantini MG, Tolnay M, Uchihara T (2015) PART is part of Alzheimer disease. Acta Neuropathol 129:749\u2013756","journal-title":"Acta Neuropathol"},{"key":"2449_CR44","doi-asserted-by":"crossref","first-page":"e1276","DOI":"10.1212\/WNL.0000000000012598","volume":"97","author":"WS Eikelboom","year":"2021","unstructured":"Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, Teunissen CE, van Berckel BNM, Pijnenburg YAL, Scheltens P, van der Flier WM, Ossenkoppele R, Papma JM (2021) Neuropsychiatric and cognitive symptoms across the Alzheimer disease clinical spectrum: cross-sectional and longitudinal associations. Neurology 97:e1276\u2013e1287","journal-title":"Neurology"},{"key":"2449_CR45","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/brain\/awab112","volume":"144","author":"M Ewers","year":"2021","unstructured":"Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, Fagan AM, McDade E, Allegri R, Berman S, Chui H, Cruchaga C, Farlow M, Graff-Radford N, Jucker M, Lee JH, Martins RN, Mori H, Perrin R, Xiong C, Rossor M, Fox NC, O\u2019Connor A, Salloway S, Danek A, Buerger K, Bateman RJ, Habeck C, Stern Y, Franzmeier N (2021) Segregation of functional networks is associated with cognitive resilience in Alzheimer\u2019s disease. Brain 144:2176\u20132185","journal-title":"Brain"},{"key":"2449_CR46","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"101","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S (2021) The complexity of Alzheimer\u2019s disease: an evolving puzzle. Physiol Rev 101:1047\u20131081","journal-title":"Physiol Rev"},{"key":"2449_CR47","doi-asserted-by":"crossref","first-page":"46263","DOI":"10.1038\/srep46263","volume":"7","author":"D Ferreira","year":"2017","unstructured":"Ferreira D, Verhagen C, Hernandez-Cabrera JA, Cavallin L, Guo CJ, Ekman U, Muehlboeck JS, Simmons A, Barroso J, Wahlund LO, Westman E (2017) Distinct subtypes of Alzheimer\u2019s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep 7:46263","journal-title":"Sci Rep"},{"key":"2449_CR48","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fneur.2019.00524","volume":"10","author":"D Ferreira","year":"2019","unstructured":"Ferreira D, Pereira JB, Volpe G, Westman E (2019) Subtypes of Alzheimer\u2019s disease display distinct network abnormalities extending beyond their pattern of brain atrophy. Front Neurol 10:524","journal-title":"Front Neurol"},{"key":"2449_CR49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Nordberg A, Westman E (2020) Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology 94:436\u2013448","journal-title":"Neurology"},{"key":"2449_CR50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/nan.12618","volume":"46","author":"I Ferrer","year":"2020","unstructured":"Ferrer I, Andr\u00e9s-Benito P (2020) White matter alterations in Alzheimer\u2019s disease without concomitant pathologies. Neuropathol Appl Neurobiol 46:654\u2013672","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2449_CR51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","volume":"77","author":"AS Fleisher","year":"2020","unstructured":"Fleisher AS, Pontecorvo MJ, Devous MD Sr, Lu M, Arora AK, Truocchio SP, Aldea P, Flitter M, Locascio T, Devine M, Siderowf A, Beach TG, Montine TJ, Serrano GE, Curtis C, Perrin A, Salloway S, Daniel M, Wellman C, Joshi AD, Irwin DJ, Lowe VJ, Seeley WW, Ikonomovic MD, Masdeu JC, Kennedy I, Harris T, Navitsky M, Southekal S, Mintun MA (2020) Positron emission tomography imaging with [18f]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol 77:829\u2013839","journal-title":"JAMA Neurol"},{"key":"2449_CR52","doi-asserted-by":"crossref","first-page":"110102","DOI":"10.1016\/j.jtbi.2019.110102","volume":"486","author":"S Fornari","year":"2020","unstructured":"Fornari S, Sch\u00e4fer A, Kuhl E, Goriely A (2020) Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome. J Theor Biol 486:110102","journal-title":"J Theor Biol"},{"key":"2449_CR53","doi-asserted-by":"crossref","unstructured":"Galili T, Mitelpunkt A, Shachar N, Marcus-Kalish M, Benjamini Y (2014) Categorize, cluster, and classify: a 3-C strategy for scientific discovery in the medical informatics platform of the Human Brain Project. In: D\u017eeroski S, Panov P, Kocev D, Todorovski L (eds) Discovery science. DS 2014. Lecture notes in computer science, vol 8777. Springer, Cham","DOI":"10.1007\/978-3-319-11812-3_7"},{"issue":"Pt 3","key":"2449_CR54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/brain\/123.3.484","volume":"123","author":"CJ Galton","year":"2000","unstructured":"Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer\u2019s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123(Pt 3):484\u2013498","journal-title":"Brain"},{"key":"2449_CR55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jnen\/nlaa014","volume":"79","author":"K Gauthreaux","year":"2020","unstructured":"Gauthreaux K, Bonnett TA, Besser LM, Brenowitz WD, Teylan M, Mock C, Chen YC, Chan KCG, Keene CD, Zhou XH, Kukull WA (2020) Concordance of clinical Alzheimer diagnosis and neuropathological features at autopsy. J Neuropathol Exp Neurol 79:465\u2013473","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR56","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/brain\/aws076","volume":"135","author":"T Gefen","year":"2012","unstructured":"Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E, Wieneke C, Bigio E, Geula C, Mesulam MM (2012) Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain 135:1554\u20131565","journal-title":"Brain"},{"key":"2449_CR57","doi-asserted-by":"crossref","first-page":"14865","DOI":"10.1002\/jcp.28308","volume":"234","author":"G Giovacchini","year":"2019","unstructured":"Giovacchini G, Giovannini E, Borso E, Lazzeri P, Riondato M, Leoncini R, Duce V, Mansi L, Ciarmiello A (2019) The brain cognitive reserve hypothesis: a review with emphasis on the contribution of nuclear medicine neuroimaging techniques. J Cell Physiol 234:14865\u201314872","journal-title":"J Cell Physiol"},{"key":"2449_CR58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-019-02053-5","volume":"138","author":"LA Gomes","year":"2019","unstructured":"Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR (2019) Abeta-induced acceleration of Alzheimer-related tau-pathology spreading and its association with prion protein. Acta Neuropathol 138:913\u2013941","journal-title":"Acta Neuropathol"},{"key":"2449_CR59","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3389\/fphar.2019.01062","volume":"10","author":"RT Gottesman","year":"2019","unstructured":"Gottesman RT, Stern Y (2019) Behavioral and psychiatric symptoms of dementia and rate of decline in Alzheimer\u2019s disease. Front Pharmacol 10:1062","journal-title":"Front Pharmacol"},{"issue":"3","key":"2449_CR60","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"Jonathan Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME (2021) New insights into atypical Alzheimer's disease in the era of biomarkers. Lancet Neurol 20:222\u2013234","journal-title":"The Lancet Neurology"},{"key":"2449_CR61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","volume":"35","author":"LT Grinberg","year":"2009","unstructured":"Grinberg LT, R\u00fcb U, Ferretti RE, Nitrini R, Farfel JM, Polichiso L, Gierga K, Jacob-Filho W, Heinsen H (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406\u2013416","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2449_CR62","doi-asserted-by":"crossref","unstructured":"Groot C, Grothe MJ, Mukherjee S, Jelistratova I, Jansen I, van Loenhoud AC, Risacher SL, Saykin AJ, Mac Donald CL, Mez J, Trittschuh EH, Gryglewski G, Lanzenberger R, Pijnenburg YAL, Barkhof F, Scheltens P, van der Flier WM, Crane PK, Ossenkoppele R (2021b) Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups. Neuroimage Clin 30:102660","DOI":"10.1016\/j.nicl.2021.102660"},{"key":"2449_CR63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2020.09.017","volume":"97","author":"C Groot","year":"2021","unstructured":"Groot C, Dor\u00e9 V, Robertson J, Burnham SC, Savage G, Ossenkoppele R, Rowe CC, Villemagne VL (2021) Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-beta-negative cognitively normal individuals. Neurobiol Aging 97:41\u201348","journal-title":"Neurobiol Aging"},{"key":"2449_CR64","first-page":"2755","volume":"141","author":"MJ Grothe","year":"2018","unstructured":"Grothe MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, Sch\u00f6ll M, Hansson O, Teipel SJ (2018) Molecular properties underlying regional vulnerability to Alzheimer\u2019s disease pathology. Brain 141:2755\u20132771","journal-title":"Brain"},{"key":"2449_CR65","doi-asserted-by":"crossref","first-page":"101346","DOI":"10.1016\/j.arr.2021.101346","volume":"69","author":"H Hampel","year":"2021","unstructured":"Hampel H, Nistic\u00f2 R, Seyfried NT, Levey AI, Modeste E, Lemercier P, Baldacci F, Toschi N, Garaci F, Perry G, Emanuele E, Valenzuela PL, Lucia A, Urbani A, Sancesario GM, Mapstone M, Corbo M, Vergallo A, Lista S (2021) Omics sciences for systems biology in Alzheimer\u2019s disease: state-of-the-art of the evidence. Ageing Res Rev 69:101346","journal-title":"Ageing Res Rev"},{"key":"2449_CR66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","volume":"77","author":"FS Hanna Al-Shaikh","year":"2020","unstructured":"Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM, Ross OA, Ertekin-Taner N, Pedraza O, Dickson DW, Graff-Radford NR, Murray ME (2020) Selective vulnerability of the nucleus basalis of Meynert among neuropathologic subtypes of Alzheimer disease. JAMA Neurol 77:225\u2013233","journal-title":"JAMA Neurol"},{"key":"2449_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M et al (1990) The Lewy body variant of Alzheimer\u2019s disease: a clinical and pathologic entity. Neurology 40:1\u20138","journal-title":"Neurology"},{"key":"2449_CR68","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02360-w","volume":"142","author":"WT Harrison","year":"2021","unstructured":"Harrison WT, Lusk JB, Liu B, Ervin JF, Johnson KG, Green CL, Wang SJ (2021) Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old. Acta Neuropathol 142:917\u2013919","journal-title":"Acta Neuropathol"},{"key":"2449_CR69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11910-020-01063-1","volume":"20","author":"RA Hickman","year":"2020","unstructured":"Hickman RA, Flowers XE, Wisniewski T (2020) Primary age-related tauopathy (PART): addressing the spectrum of neuronal tauopathic changes in the aging brain. Curr Neurol Neurosci Rep 20:39","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2449_CR70","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/tp.2012.38","volume":"2","author":"WG Honer","year":"2012","unstructured":"Honer WG, Barr AM, Sawada K, Thornton AE, Morris MC, Leurgans SE, Schneider JA, Bennett DA (2012) Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry 2:e114","journal-title":"Transl Psychiatry"},{"key":"2449_CR71","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/15548627.2018.1461294","volume":"14","author":"X Hou","year":"2018","unstructured":"Hou X, Fiesel FC, Truban D, Castanedes Casey M, Lin WL, Soto AI, Tacik P, Rousseau LG, Diehl NN, Heckman MG, Lorenzo-Betancor O, Ferrer I, Arbelo JM, Steele JC, Farrer MJ, Cornejo-Olivas M, Torres L, Mata IF, Graff-Radford NR, Wszolek ZK, Ross OA, Murray ME, Dickson DW, Springer W (2018) Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Autophagy 14:1404\u20131418","journal-title":"Autophagy"},{"key":"2449_CR72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.dadm.2015.11.008","volume":"2","author":"J Hwang","year":"2015","unstructured":"Hwang J, Kim CM, Jeon S, Lee JM, Hong YJ, Roh JH, Lee JH, Koh JY, Na DL (2015) Prediction of Alzheimer\u2019s disease pathophysiology based on cortical thickness patterns. Alzheimers Dement (amst) 2:58\u201367","journal-title":"Alzheimers Dement (amst)"},{"key":"2449_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313","journal-title":"Alzheimers Dement"},{"key":"2449_CR74","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"L Iaccarino","year":"2017","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O\u2019Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD (2017) Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s Disease. Neuroimage Clin 17:452\u2013464","journal-title":"Neuroimage Clin"},{"key":"2449_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhaa184","volume":"31","author":"L Iaccarino","year":"2021","unstructured":"Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD (2021) Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer\u2019s disease continuum. Cereb Cortex 31:1\u201314","journal-title":"Cereb Cortex"},{"key":"2449_CR76","doi-asserted-by":"publisher","unstructured":"Ikeda M, Kodaira S, Kasahara H, Takai E, Nagashima K, Fujita Y, Makioka K, Hirayanagi K, Furuta N, Furuta M, Sanada E, Kobayashi A, Harigaya Y, Nagamine S, Hattori N, Tashiro Y, Kishi K, Shimada H, Suto T, Tanaka H, Sakai Y, Yamazaki T, Tanaka Y, Aihara Y, Amari M, Yamaguchi H, Okamoto K, Takatama M, Ishii K, Higuchi T, Tsushima Y, Ikeda Y (2021) Cerebral microbleeds, cerebrospinal fluid, and neuroimaging markers in clinical subtypes of Alzheimer's disease. Front Neurol 12:543866\u00a0https:\/\/doi.org\/10.3389\/fneur.2021.543866","DOI":"10.3389\/fneur.2021.543866"},{"key":"2449_CR77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R (2018a) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562","journal-title":"Alzheimers Dement"},{"key":"2449_CR78","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC (2018b) Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain 141:1517\u20131528","journal-title":"Brain"},{"key":"2449_CR79","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","volume":"76","author":"CR Jack Jr","year":"2019","unstructured":"Jack CR Jr, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, Lowe VJ, Mielke MM, Roberts RO, Machulda MM, Graff-Radford J, Jones DT, Schwarz CG, Gunter JL, Senjem ML, Rocca WA, Petersen RC (2019) Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer\u2019s Association Research Framework. JAMA Neurol 76:1174\u20131183","journal-title":"JAMA Neurol"},{"key":"2449_CR80","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-200680","volume":"78","author":"H Jang","year":"2020","unstructured":"Jang H, Kim HJ, Choe YS, Kim SJ, Park S, Kim Y, Kim KW, Lyoo CH, Cho H, Ryu YH, Choi JY, DeCarli C, Na DL, Seo SW (2020) The impact of amyloid-beta or tau on cognitive change in the presence of severe cerebrovascular disease. J Alzheimers Dis 78:573\u2013585","journal-title":"J Alzheimers Dis"},{"key":"2449_CR81","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-012-1044-y","volume":"124","author":"NJ Janocko","year":"2012","unstructured":"Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R, Graff-Radford NR, Dickson DW, Murray ME (2012) Neuropathologically defined subtypes of Alzheimer\u2019s disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681\u2013692","journal-title":"Acta Neuropathol"},{"key":"2449_CR82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2006-9S308","volume":"9","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA (2006) Clinicopathological analysis of dementia disorders in the elderly\u2014an update. J Alzheimers Dis 9:61\u201370","journal-title":"J Alzheimers Dis"},{"key":"2449_CR83","unstructured":"Jellinger KA (2011) Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? In: Braissant O, Wakamatsu H, Liu IKK, Allegaert K, Lenbury Y, Wachholtz A (eds) Recent researches in modern medicine. Proceedings of the WSEAS international conferences in Cambridge, UK, Feb. 23\u201325, 2011. WSEAS Press, Cambridge, pp 71\u201397"},{"key":"2449_CR84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-011-0889-9","volume":"123","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathological subtypes of Alzheimer\u2019s disease (correspondence). Acta Neuropathol 123:153\u2013154","journal-title":"Acta Neuropathol"},{"key":"2449_CR85","doi-asserted-by":"crossref","first-page":"1000480","DOI":"10.4172\/2155-9899.1000480","volume":"7","author":"KA Jellinger","year":"2016","unstructured":"Jellinger KA (2016) Commentary on the paper \u201cPART, a distinct tauopathy, different from classical sporadic Alzheimer disease.\u201d J Clin Cell Immunol 7:1000480","journal-title":"J Clin Cell Immunol"},{"key":"2449_CR86","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-018-1894-z","volume":"136","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA (2018) Different patterns of hippocampal tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol 136:811\u2013813","journal-title":"Acta Neuropathol"},{"key":"2449_CR87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.17879\/freeneuropathology-12020-13050","volume":"1","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA (2020) Neuropathology of the Alzheimer\u2019s continuum: an update. Free Neuropathol 1:32. https:\/\/doi.org\/10.17879\/freeneuropathology-12020-13050","journal-title":"Free Neuropathol"},{"key":"2449_CR88","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2007.01.045","volume":"257","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Attems J (2007) Neuropathological evaluation of mixed dementia. J Neurol Sci 257:80\u201387","journal-title":"J Neurol Sci"},{"key":"2449_CR89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-010-0654-5","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 119:421\u2013433","journal-title":"Acta Neuropathol"},{"key":"2449_CR90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00702-014-1288-x","volume":"122","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA, Attems J (2015) Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (vienna) 122:505\u2013521","journal-title":"J Neural Transm (vienna)"},{"key":"2449_CR91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-010-0712-z","volume":"121","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA, Grazer A, Petrovic K, Ropele S, Alpi G, Kapeller P, Strobel T, Schmidt R (2011) Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Acta Neuropathol 121:267\u2013277","journal-title":"Acta Neuropathol"},{"key":"2449_CR92","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","volume":"129","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR Jr, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, Montine TJ, Nelson PT, Schmitt F, Schneider JA, Serrano-Pozo A, Thal DR, Toledo JB, Trojanowski JQ, Troncoso JC, Vonsattel JP, Wisniewski T (2015) PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol 129:757\u2013762","journal-title":"Acta Neuropathol"},{"key":"2449_CR93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fnagi.2019.00211","volume":"11","author":"S Jeon","year":"2019","unstructured":"Jeon S, Kang JM, Seo S, Jeong HJ, Funck T, Lee SY, Park KH, Lee YB, Yeon BK, Ido T, Okamura N, Evans AC, Na DL, Noh Y (2019) Topographical heterogeneity of Alzheimer\u2019s disease based on MR imaging, tau PET, and amyloid PET. Front Aging Neurosci 11:211","journal-title":"Front Aging Neurosci"},{"key":"2449_CR94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cortex.2017.09.018","volume":"97","author":"DT Jones","year":"2017","unstructured":"Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr (2017) Tau, amyloid, and cascading network failure across the Alzheimer\u2019s disease spectrum. Cortex 97:143\u2013159","journal-title":"Cortex"},{"key":"2449_CR95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, Petersen RC, Dickson DW (2014) Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol 127:441\u2013450","journal-title":"Acta Neuropathol"},{"key":"2449_CR96","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24493","volume":"78","author":"KA Josephs","year":"2015","unstructured":"Josephs KA, Whitwell JL, Tosakulwong N, Weigand SD, Murray ME, Liesinger AM, Petrucelli L, Senjem ML, Ivnik RJ, Parisi JE, Petersen RC, Dickson DW (2015) TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features. Ann Neurol 78:697\u2013709","journal-title":"Ann Neurol"},{"key":"2449_CR97","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","volume":"131","author":"KA Josephs","year":"2016","unstructured":"Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, Liesinger AM, Petersen RC, Parisi JE, Dickson DW (2016) Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol 131:571\u2013585","journal-title":"Acta Neuropathol"},{"key":"2449_CR98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","volume":"133","author":"KA Josephs","year":"2017","unstructured":"Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Dickson DW (2017) Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol 133:705\u2013715","journal-title":"Acta Neuropathol"},{"key":"2449_CR99","doi-asserted-by":"crossref","first-page":"e2673","DOI":"10.1212\/WNL.0000000000012022","volume":"96","author":"RJ Jutten","year":"2021","unstructured":"Jutten RJ, Sikkes SAM, Van der Flier WM, Scheltens P, Visser PJ, Tijms BM (2021) Finding treatment effects in Alzheimer trials in the face of disease progression heterogeneity. Neurology 96:e2673\u2013e2684","journal-title":"Neurology"},{"key":"2449_CR100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171\u2013186","journal-title":"Acta Neuropathol"},{"key":"2449_CR101","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jamaneurol.2021.3123","volume":"78","author":"J Karlawish","year":"2021","unstructured":"Karlawish J (2021) Aducanumab and the business of Alzheimer disease\u2014some choice. JAMA Neurol 78:1303\u20131304","journal-title":"JAMA Neurol"},{"key":"2449_CR102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","volume":"136","author":"SK Kaufman","year":"2018","unstructured":"Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI (2018) Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer\u2019s disease and PART. Acta Neuropathol 136:57\u201367","journal-title":"Acta Neuropathol"},{"key":"2449_CR103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/brainsci10080479","volume":"10","author":"A King","year":"2020","unstructured":"King A, Bodi I, Troakes C (2020) The neuropathological diagnosis of Alzheimer\u2019s disease\u2014the challenges of pathological mimics and concomitant pathology. Brain Sci 10:479","journal-title":"Brain Sci"},{"key":"2449_CR104","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jalz.2018.03.002","volume":"14","author":"DS Knopman","year":"2018","unstructured":"Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, Maruff P, Miller DS, Tong G, Tome MB, Murray ME, Nelson PT, Sano M, Mattsson N, Sultzer DL, Montine TJ, Jack CR Jr, Kolb H, Petersen RC, Vemuri P, Canniere MZ, Schneider JA, Resnick SM, Romano G, van Harten AC, Wolk DA, Bain LJ, Siemers E (2018) The National Institute on Aging and the Alzheimer\u2019s Association Research Framework for Alzheimer\u2019s disease: perspectives from the research roundtable. Alzheimers Dement 14:563\u2013575","journal-title":"Alzheimers Dement"},{"key":"2449_CR105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00401-019-02103-y","volume":"139","author":"MJ Koper","year":"2020","unstructured":"Koper MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Tousseyn T, Balusu S, De Strooper B, Thal DR (2020) Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer\u2019s disease. Acta Neuropathol 139:463\u2013484","journal-title":"Acta Neuropathol"},{"key":"2449_CR106","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.119.230458","volume":"61","author":"I Koychev","year":"2020","unstructured":"Koychev I, Hofer M, Friedman N (2020) Correlation of Alzheimer disease neuropathologic staging with amyloid and tau scintigraphic imaging biomarkers. J Nucl Med 61:1413\u20131418","journal-title":"J Nucl Med"},{"key":"2449_CR107","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1212\/WNL.0000000000011270","volume":"96","author":"R La Joie","year":"2021","unstructured":"La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD (2021) Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology 96:e650\u2013e661","journal-title":"Neurology"},{"key":"2449_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","volume":"5","author":"B Lam","year":"2013","unstructured":"Lam B, Masellis M, Freedman M, Stuss DT, Black SE (2013) Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome. Alzheimers Res Ther 5:1","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-020-02201-2","volume":"142","author":"HHC Lau","year":"2021","unstructured":"Lau HHC, Ingelsson M, Watts JC (2021) The existence of Abeta strains and their potential for driving phenotypic heterogeneity in Alzheimer\u2019s disease. Acta Neuropathol 142:17\u201339","journal-title":"Acta Neuropathol"},{"key":"2449_CR110","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/brain\/aws327","volume":"136","author":"M Lehmann","year":"2013","unstructured":"Lehmann M, Ghosh PM, Madison C, Laforce R Jr, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD (2013) Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease. Brain 136:844\u2013858","journal-title":"Brain"},{"key":"2449_CR111","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.25968","volume":"89","author":"OH Lesman-Segev","year":"2021","unstructured":"Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD (2021) Diagnostic accuracy of amyloid versus (18) F-fluorodeoxyglucose positron emission tomography in autopsy-confirmed dementia. Ann Neurol 89:389\u2013401","journal-title":"Ann Neurol"},{"key":"2449_CR112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13195-021-00785-9","volume":"13","author":"F Levin","year":"2021","unstructured":"Levin F, Ferreira D, Lange C, Dyrba M, Westman E, Buchert R, Teipel SJ, Grothe MJ (2021) Data-driven FDG-PET subtypes of Alzheimer\u2019s disease-related neurodegeneration. Alzheimers Res Ther 13:49","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR113","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1212\/WNL.43.2.305","volume":"43","author":"DN Levine","year":"1993","unstructured":"Levine DN, Lee JM, Fisher CM (1993) The visual variant of Alzheimer\u2019s disease: a clinicopathologic case study. Neurology 43:305\u2013313","journal-title":"Neurology"},{"key":"2449_CR114","doi-asserted-by":"crossref","first-page":"e01548","DOI":"10.1002\/brb3.1548","volume":"10","author":"CH Li","year":"2020","unstructured":"Li CH, Fan SP, Chen TF, Chiu MJ, Yen RF, Lin CH (2020) Frontal variant of Alzheimer\u2019s disease with asymmetric presentation mimicking frontotemporal dementia: case report and literature review. Brain Behav 10:e01548","journal-title":"Brain Behav"},{"key":"2449_CR115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-021-00557-x","volume":"17","author":"KY Liu","year":"2021","unstructured":"Liu KY, Howard R (2021) Can we learn lessons from the FDA\u2019s approval of aducanumab? Nat Rev Neurol 17:715\u2013722","journal-title":"Nat Rev Neurol"},{"key":"2449_CR116","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1093\/brain\/awaa315","volume":"143","author":"KY Liu","year":"2020","unstructured":"Liu KY, Reeves S, McAleese KE, Attems J, Francis P, Thomas A, Howard R (2020) Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer\u2019s disease. Brain 143:3842\u20133849","journal-title":"Brain"},{"key":"2449_CR117","doi-asserted-by":"crossref","first-page":"101267","DOI":"10.1016\/j.jbc.2021.101267","volume":"297","author":"H Liu","year":"2021","unstructured":"Liu H, Kim C, Haldiman T, Sigurdson CJ, Nystr\u00f6m S, Nilsson KPR, Cohen ML, Wisniewski T, Hammarstr\u00f6m P, Safar JG (2021) Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer\u2019s disease. J Biol Chem 297:101267","journal-title":"J Biol Chem"},{"key":"2449_CR118","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339","journal-title":"Cell"},{"key":"2449_CR119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-020-00620-7","volume":"12","author":"A Machado","year":"2020","unstructured":"Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger \u00c3, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M (2020) The cholinergic system in subtypes of Alzheimer\u2019s disease: an in vivo longitudinal MRI study. Alzheimers Res Ther 12:51","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JAD-191151","volume":"74","author":"M Malek-Ahmadi","year":"2020","unstructured":"Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ (2020) Braak stage, cerebral amyloid angiopathy, and cognitive decline in early Alzheimer\u2019s disease. J Alzheimers Dis 74:189\u2013197","journal-title":"J Alzheimers Dis"},{"key":"2449_CR121","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-020-02248-1","volume":"141","author":"BJ Matchett","year":"2021","unstructured":"Matchett BJ, Grinberg LT, Theofilas P, Murray ME (2021) The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 141:631\u2013650","journal-title":"Acta Neuropathol"},{"key":"2449_CR122","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2019.08.005","volume":"73","author":"R Matej","year":"2019","unstructured":"Matej R, Tesar A, Rusina R (2019) Alzheimer\u2019s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem 73:26\u201331","journal-title":"Clin Biochem"},{"key":"2449_CR123","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/jnnp-2015-311321","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Schott JM, Hardy J, Turner MR, Zetterberg H (2016) Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 87:1000\u20131004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2449_CR124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-018-0403-x","volume":"10","author":"N Mattsson","year":"2018","unstructured":"Mattsson N, Ossenkoppele R, Smith R, Strandberg O, Ohlsson T, Jogi J, Palmqvist S, Stomrud E, Hansson O (2018) Greater tau load and reduced cortical thickness in APOE epsilon4-negative Alzheimer\u2019s disease: a cohort study. Alzheimers Res Ther 10:77","journal-title":"Alzheimers Res Ther"},{"issue":"Suppl. 1","key":"2449_CR125","first-page":"37","volume":"46","author":"KE McAleese","year":"2020","unstructured":"McAleese KE, Walker L, Erskine D, Attems J (2020) The impact of concomitant LATE-NC on hyperphosphorylated-s pathology and cognitive decline in Alzheimer\u2019s disease (abstract). Neuropathol Appl Neurobiol 46(Suppl. 1):37","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2449_CR126","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/alz.12291","volume":"17","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J, Roncaroli F, Love S, Francis PT, Attems J (2021a) Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimers Dement 17:1121\u20131133","journal-title":"Alzheimers Dement"},{"key":"2449_CR127","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00401-021-02376-2","volume":"142","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Miah M, Graham S, Hadfield GM, Walker L, Johnson M, Colloby SJ, Thomas AJ, DeCarli C, Koss D, Attems J (2021b) Frontal white matter lesions in Alzheimer\u2019s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathol 142:937\u2013950","journal-title":"Acta Neuropathol"},{"key":"2449_CR128","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.0000000000003119","volume":"87","author":"CT McMillan","year":"2016","unstructured":"McMillan CT, Boyd C, Gross RG, Weinstein J, Firn K, Toledo JB, Rascovsky K, Shaw L, Wolk DA, Irwin DJ, Lee EB, Trojanowski JQ, Grossman M (2016) Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndrome. Neurology 87:1227\u20131234","journal-title":"Neurology"},{"key":"2449_CR129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/WCO.0000000000000912","volume":"34","author":"RI Mehta","year":"2021","unstructured":"Mehta RI, Schneider JA (2021) What is \u2018Alzheimer\u2019s disease\u2019? The neuropathological heterogeneity of clinically defined Alzheimer\u2019s dementia. Curr Opin Neurol 34:237\u2013245","journal-title":"Curr Opin Neurol"},{"key":"2449_CR130","doi-asserted-by":"crossref","first-page":"e916","DOI":"10.1212\/WNL.0000000000011397","volume":"96","author":"MM Mesulam","year":"2021","unstructured":"Mesulam MM, Coventry C, Kuang A, Bigio EH, Mao Q, Flanagan ME, Gefen T, Sridhar J, Geula C, Zhang H, Weintraub S, Rogalski EJ (2021) Memory resilience in Alzheimer disease with primary progressive aphasia. Neurology 96:e916\u2013e925","journal-title":"Neurology"},{"key":"2449_CR131","first-page":"132","volume":"117","author":"SS Mirra","year":"1993","unstructured":"Mirra SS, Hart MN, Terry RD (1993) Making the diagnosis of Alzheimer\u2019s disease. A primer for practicing pathologists. Arch Pathol Lab Med 117:132\u2013144","journal-title":"Arch Pathol Lab Med"},{"key":"2449_CR132","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41598-020-57785-2","volume":"10","author":"A Mitelpunkt","year":"2020","unstructured":"Mitelpunkt A, Galili T, Kozlovski T, Bregman N, Shachar N, Markus-Kalish M, Benjamini Y (2020) Novel Alzheimer\u2019s disease subtypes identified using a data and knowledge driven strategy. Sci Rep 10:1327","journal-title":"Sci Rep"},{"key":"2449_CR133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/WAD.0000000000000380","volume":"34","author":"C Mock","year":"2020","unstructured":"Mock C, Teylan M, Beecham G, Besser L, Cairns NJ, Crary JF, Katsumata Y, Nelson PT, Kukull W (2020) The utility of the National Alzheimer\u2019s Coordinating Center\u2019s database for the rapid assessment of evolving neuropathologic conditions. Alzheimer Dis Assoc Disord 34:105\u2013111","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2449_CR134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"2449_CR135","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-00021-05493-y","author":"A Moscoso","year":"2021","unstructured":"Moscoso A, Silva-Rodr\u00edguez J, Aldrey JM, Cort\u00e9s J, P\u00edas-Peleteiro JM, Ruibal \u00c1, Aguiar P (2021) (18)F-florbetapir PET as a marker of myelin integrity across the Alzheimer\u2019s disease spectrum. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-00021-05493-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2449_CR136","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-019-02054-4","volume":"138","author":"D Mrdjen","year":"2019","unstructured":"Mrdjen D, Fox EJ, Bukhari SA, Montine KS, Bendall SC, Montine TJ (2019) The basis of cellular and regional vulnerability in Alzheimer\u2019s disease. Acta Neuropathol 138:729\u2013749","journal-title":"Acta Neuropathol"},{"key":"2449_CR137","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1038\/s41380-018-0298-8","volume":"25","author":"S Mukherjee","year":"2020","unstructured":"Mukherjee S, Mez J, Trittschuh EH, Saykin AJ, Gibbons LE, Fardo DW, Wessels M, Bauman J, Moore M, Choi SE, Gross AL, Rich J, Louden DKN, Sanders RE, Grabowski TJ, Bird TD, McCurry SM, Snitz BE, Kamboh MI, Lopez OL, De Jager PL, Bennett DA, Keene CD, Larson EB, Crane PK (2020) Genetic data and cognitively defined late-onset Alzheimer\u2019s disease subgroups. Mol Psychiatry 25:2942\u20132951","journal-title":"Mol Psychiatry"},{"key":"2449_CR138","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785\u2013796","journal-title":"Lancet Neurol"},{"key":"2449_CR139","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-014-1302-2","volume":"128","author":"ME Murray","year":"2014","unstructured":"Murray ME, Cannon A, Graff-Radford NR, Liesinger AM, Rutherford NJ, Ross OA, Duara R, Carrasquillo MM, Rademakers R, Dickson DW (2014) Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol 128:411\u2013421","journal-title":"Acta Neuropathol"},{"key":"2449_CR140","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR Jr, Dickson DW (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain 138:1370\u20131381","journal-title":"Brain"},{"key":"2449_CR141","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamaneurol.2020.4478","volume":"78","author":"ES Musiek","year":"2021","unstructured":"Musiek ES, Morris JC (2021) Possible consequences of the approval of a disease-modifying therapy for Alzheimer disease. JAMA Neurol 78:141\u2013142","journal-title":"JAMA Neurol"},{"key":"2449_CR142","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neurobiolaging.2016.08.001","volume":"47","author":"HK Na","year":"2016","unstructured":"Na HK, Kang DR, Kim S, Seo SW, Heilman KM, Noh Y, Na DL (2016) Malignant progression in parietal-dominant atrophy subtype of Alzheimer\u2019s disease occurs independent of onset age. Neurobiol Aging 47:149\u2013156","journal-title":"Neurobiol Aging"},{"key":"2449_CR143","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3233\/JAD-190302","volume":"70","author":"C Nance","year":"2019","unstructured":"Nance C, Ritter A, Miller JB, Lapin B, Banks SJ (2019) The pathology of rapid cognitive decline in clinically diagnosed Alzheimer\u2019s disease. J Alzheimers Dis 70:983\u2013993","journal-title":"J Alzheimers Dis"},{"key":"2449_CR144","doi-asserted-by":"publisher","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, Wang E, Horgusluoglu-Moloch E, Song WM, Li A, Castranio EL, Tcw J, Ho L, Goate A, Fossati V, Noggle S, Gandy S, Ehrlich ME, Katsel P, Schadt E, Cai D, Brennand KJ, Haroutunian V, Zhang B (2021) Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7. https:\/\/doi.org\/10.1126\/sciadv.abb5398","DOI":"10.1126\/sciadv.abb5398"},{"key":"2449_CR145","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/brain\/awr053","volume":"134","author":"PT Nelson","year":"2011","unstructured":"Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, Van Eldik LJ, Kryscio RJ (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134:1506\u20131518","journal-title":"Brain"},{"key":"2449_CR146","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362\u2013381","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR147","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jnen\/nlw033","volume":"75","author":"PT Nelson","year":"2016","unstructured":"Nelson PT, Trojanowski JQ, Abner EL, Al-Janabi OM, Jicha GA, Schmitt FA, Smith CD, Fardo DW, Wang WX, Kryscio RJ, Neltner JH, Kukull WA, Cykowski MD, Van Eldik LJ, Ighodaro ET (2016) \u201cNew Old Pathologies\u201d: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS). J Neuropathol Exp Neurol 75:482\u2013498","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR148","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142:1503\u20131527","journal-title":"Brain"},{"key":"2449_CR149","doi-asserted-by":"crossref","first-page":"105754","DOI":"10.1016\/j.phrs.2021.105754","volume":"171","author":"R Nistic\u00f2","year":"2021","unstructured":"Nistic\u00f2 R, Borg JJ (2021) Aducanumab for Alzheimer\u2019s disease: a regulatory perspective. Pharmacol Res 171:105754","journal-title":"Pharmacol Res"},{"key":"2449_CR150","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1212\/WNL.0000000000001003","volume":"83","author":"Y Noh","year":"2014","unstructured":"Noh Y, Jeon S, Lee JM, Seo SW, Kim GH, Cho H, Ye BS, Yoon CW, Kim HJ, Chin J, Park KH, Heilman KM, Na DL (2014) Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology 83:1936\u20131944","journal-title":"Neurology"},{"key":"2449_CR151","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02566-9","author":"A Noor","year":"2021","unstructured":"Noor A, Zafar S, Shafiq M, Younas N, Siegert A, Mann FA, Kruss S, Schmitz M, Dihazi H, Ferrer I, Zerr I (2021) Molecular profiles of amyloid-beta proteoforms in typical and rapidly progressive Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-021-02566-9","journal-title":"Mol Neurobiol"},{"key":"2449_CR152","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bpa.12902","volume":"31","author":"DT Ohm","year":"2021","unstructured":"Ohm DT, Fought AJ, Martersteck A, Coventry C, Sridhar J, Gefen T, Weintraub S, Bigio E, Mesulam MM, Rogalski E, Geula C (2021) Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease. Brain Pathol 31:189\u2013204","journal-title":"Brain Pathol"},{"key":"2449_CR153","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jalz.2018.09.011","volume":"15","author":"K Oppedal","year":"2019","unstructured":"Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snaedal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D (2019) A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium. Alzheimers Dement 15:400\u2013409","journal-title":"Alzheimers Dement"},{"key":"2449_CR154","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","volume":"138","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust WJ, Scheltens P, Seeley WW, Rabinovici GD (2015) The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features. Brain 138:2732\u20132749","journal-title":"Brain"},{"key":"2449_CR155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jalz.2019.08.201","volume":"16","author":"R Ossenkoppele","year":"2020","unstructured":"Ossenkoppele R, Lyoo CH, Sudre CH, van Westen D, Cho H, Ryu YH, Choi JY, Smith R, Strandberg O, Palmqvist S, Westman E, Tsai R, Kramer J, Boxer AL, Gorno-Tempini ML, La Joie R, Miller BL, Rabinovici GD, Hansson O (2020) Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer\u2019s disease. Alzheimers Dement 16:335\u2013344","journal-title":"Alzheimers Dement"},{"key":"2449_CR156","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","volume":"78","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, J\u00f6gi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, Miller BL, Soleimani-Meigooni D, Iaccarino L, La Joie R, Baker S, Borroni E, Klein G, Pontecorvo MJ, Devous MD Sr, Jagust WJ, Lyoo CH, Rabinovici GD, Hansson O (2021) Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol 78:961\u2013971","journal-title":"JAMA Neurol"},{"key":"2449_CR157","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/WNN.0000000000000251","volume":"33","author":"V Paquin","year":"2020","unstructured":"Paquin V, Therriault J, Pascoal TA, Rosa-Neto P, Gauthier S (2020) Frontal variant of Alzheimer disease differentiated from frontotemporal dementia using in vivo amyloid and tau imaging. Cogn Behav Neurol 33:288\u2013293","journal-title":"Cogn Behav Neurol"},{"key":"2449_CR158","doi-asserted-by":"publisher","first-page":"43270","DOI":"10.1038\/srep43270","volume":"7","author":"JY Park","year":"2017","unstructured":"Park JY, Na HK, Kim S, Kim H, Kim HJ, Seo SW, Na DL, Han CE, Seong JK (2017) Robust identification of Alzheimer's disease subtypes based on cortical atrophy patterns. Sci Rep 7:43270 https:\/\/doi.org\/10.1038\/srep43270","journal-title":"Sci Rep"},{"key":"2449_CR159","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13195-021-00876-7","volume":"13","author":"W Pelkmans","year":"2021","unstructured":"Pelkmans W, Ossenkoppele R, Dicks E, Strandberg O, Barkhof F, Tijms BM, Pereira JB, Hansson O (2021) Tau-related grey matter network breakdown across the Alzheimer\u2019s disease continuum. Alzheimers Res Ther 13:138","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R, Zetterberg H, Blennow K, Hansson O (2021) Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer\u2019s disease. Brain 144:310\u2013324","journal-title":"Brain"},{"key":"2449_CR161","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","volume":"138","author":"C Petersen","year":"2019","unstructured":"Petersen C, Nolan AL, de Paula Franca Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML, Rosen HJ, Kramer JH, Spina S, Rabinovici GD, Miller BL, Seeley WW, Heinsen H, Grinberg LT (2019) Alzheimer\u2019s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol 138:597\u2013612","journal-title":"Acta Neuropathol"},{"key":"2449_CR162","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504341","volume":"48","author":"ML Phillips","year":"2019","unstructured":"Phillips ML, Stage EC Jr, Lane KA, Gao S, Risacher SL, Goukasian N, Saykin AJ, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG (2019) Neurodegenerative patterns of cognitive clusters of early-onset Alzheimer\u2019s disease subjects: evidence for disease heterogeneity. Dement Geriatr Cogn Disord 48:131\u2013142","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2449_CR163","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3233\/JAD-180155","volume":"64","author":"JA Pillai","year":"2018","unstructured":"Pillai JA, Appleby BS, Safar J, Leverenz JB (2018) Rapidly progressive Alzheimer\u2019s disease in two distinct autopsy cohorts. J Alzheimers Dis 64:973\u2013980","journal-title":"J Alzheimers Dis"},{"key":"2449_CR164","doi-asserted-by":"crossref","first-page":"101482","DOI":"10.1016\/j.arr.2021.101482","volume":"72","author":"L Pini","year":"2021","unstructured":"Pini L, Wennberg AM, Salvalaggio A, Vallesi A, Pievani M, Corbetta M (2021) Breakdown of specific functional brain networks in clinical variants of Alzheimer\u2019s disease. Ageing Res Rev 72:101482","journal-title":"Ageing Res Rev"},{"key":"2449_CR165","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jamaneurol.2021.3126","volume":"78","author":"V Planche","year":"2021","unstructured":"Planche V, Villain N (2021) US Food and Drug Administration approval of aducanumab\u2014is amyloid load a valid surrogate end point for Alzheimer disease clinical trials? JAMA Neurol 78:1307-1308","journal-title":"JAMA Neurol"},{"key":"2449_CR166","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2019.03.006","volume":"79","author":"V Planche","year":"2019","unstructured":"Planche V, Coupe P, Helmer C, Le Goff M, Amieva H, Tison F, Dartigues JF, Catheline G (2019) Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer\u2019s clinical syndrome. Neurobiol Aging 79:22\u201329","journal-title":"Neurobiol Aging"},{"key":"2449_CR167","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/alz.12231","volume":"17","author":"V Planche","year":"2021","unstructured":"Planche V, Bouteloup V, Mangin JF, Dubois B, Delrieu J, Pasquier F, Blanc F, Paquet C, Hanon O, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Habert MO, Fischer C, Chupin M, B\u00e9jot Y, Godefroy O, Wallon D, Sauv\u00e9e M, Bourdel-Marchasson I, Jalenques I, Tison F, Ch\u00eane G, Dufouil C (2021) Clinical relevance of brain atrophy subtypes categorization in memory clinics. Alzheimers Dement 17:641\u2013652","journal-title":"Alzheimers Dement"},{"key":"2449_CR168","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jalz.2005.11.001","volume":"2","author":"BL Plassman","year":"2006","unstructured":"Plassman BL, Khachaturian AS, Townsend JJ, Ball MJ, Steffens DC, Leslie CE, Tschanz JT, Norton MC, Burke JR, Welsh-Bohmer KA, Hulette CM, Nixon RR, Tyrey M, Breitner JC (2006) Comparison of clinical and neuropathologic diagnoses of Alzheimer\u2019s disease in 3 epidemiologic samples. Alzheimers Dement 2:2\u201311","journal-title":"Alzheimers Dement"},{"key":"2449_CR169","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1111\/ene.15097","volume":"28","author":"M Pollet","year":"2021","unstructured":"Pollet M, Skrobala E, Lopes R, Kuchcinski G, Bordier C, Rollin-Sillaire A, Bombois S, Pasquier F, Delbeuck X (2021) A multimodal, longitudinal study of cognitive heterogeneity in early-onset Alzheimer\u2019s disease. Eur J Neurol 28:3990\u20133998","journal-title":"Eur J Neurol"},{"key":"2449_CR170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.01.009","volume":"65","author":"K Poulakis","year":"2018","unstructured":"Poulakis K, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E (2018) Heterogeneous patterns of brain atrophy in Alzheimer\u2019s disease. Neurobiol Aging 65:98\u2013108","journal-title":"Neurobiol Aging"},{"key":"2449_CR171","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.25246","volume":"84","author":"MC Power","year":"2018","unstructured":"Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY, Nudelman K, Zahodne L, Gross AL, Mungas D, Widaman KF, Schneider J (2018) Combined neuropathological pathways account for age-related risk of dementia. Ann Neurol 84:10\u201322","journal-title":"Ann Neurol"},{"key":"2449_CR172","doi-asserted-by":"crossref","first-page":"e2414","DOI":"10.1212\/WNL.0000000000011883","volume":"96","author":"J Qian","year":"2021","unstructured":"Qian J, Betensky RA, Hyman BT, Serrano-Pozo A (2021) Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer disease. Neurology 96:e2414\u2013e2428","journal-title":"Neurology"},{"issue":"7636","key":"2449_CR173","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature20814","volume":"541","author":"Wei Qiang","year":"2017","unstructured":"Qiang W, Yau WM, Lu JX, Collinge J, Tycko R (2017) Structural variation in amyloid-beta fibrils from Alzheimer's disease clinical subtypes. Nature 541:217\u2013221","journal-title":"Nature"},{"key":"2449_CR174","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","volume":"6","author":"J Rahimi","year":"2014","unstructured":"Rahimi J, Kovacs GG (2014) Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther 6:82","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-021-01154-1","volume":"9","author":"VK Ramanan","year":"2021","unstructured":"Ramanan VK, Lesnick TG, Przybelski SA, Heckman MG, Knopman DS, Graff-Radford J, Lowe VJ, Machulda MM, Mielke MM, Jack CR Jr, Petersen RC, Ross OA, Vemuri P (2021) Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer\u2019s pathophysiology. Acta Neuropathol Commun 9:48","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR176","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1093\/cercor\/bhab130","volume":"31","author":"BS Rauchmann","year":"2021","unstructured":"Rauchmann BS, Ersoezlue E, Stoecklein S, Keeser D, Brosseron F, Buerger K, Dechent P, Dobisch L, Ertl-Wagner B, Fliessbach K, Haynes JD, Heneka MT, Incesoy EI, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Ramirez A, Roeske S, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Vukovich R, Wagner M, Wiltfang J, Yakupov R, Duezel E, Jessen F, Perneczky R (2021) Resting-state network alterations differ between Alzheimer\u2019s disease atrophy subtypes. Cereb Cortex&nbsp 31:4901-4915","journal-title":"Cereb Cortex"},{"key":"2449_CR177","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.3390\/ijms21207481","volume":"21","author":"M Ricci","year":"2020","unstructured":"Ricci M, Cimini A, Chiaravalloti A, Filippi L, Schillaci O (2020) Positron emission tomography (PET) and neuroimaging in the personalized approach to neurodegenerative causes of dementia. Int J Mol Sci 21:7481. https:\/\/doi.org\/10.3390\/ijms21207481","journal-title":"Int J Mol Sci"},{"key":"2449_CR178","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","volume":"89","author":"SL Risacher","year":"2017","unstructured":"Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ, Schwarz AJ (2017) Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology 89:2176\u20132186","journal-title":"Neurology"},{"key":"2449_CR179","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181\u20132193","journal-title":"Brain"},{"key":"2449_CR180","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/brain\/awaa219","volume":"143","author":"JL Robinson","year":"2020","unstructured":"Robinson JL, Porta S, Garrett FG, Zhang P, Xie SX, Suh E, Van Deerlin VM, Abner EL, Jicha GA, Barber JM, Lee VM, Lee EB, Trojanowski JQ, Nelson PT (2020) Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain 143:2844\u20132857","journal-title":"Brain"},{"key":"2449_CR181","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","volume":"144","author":"JL Robinson","year":"2021","unstructured":"Robinson JL, Richardson H, Xie SX, Suh E, Van Deerlin VM, Alfaro B, Loh N, Porras-Paniagua M, Nirschl JJ, Wolk D, Lee VM, Lee EB, Trojanowski JQ (2021) The development and convergence of co-pathologies in Alzheimer\u2019s disease. Brain 144:953\u2013962","journal-title":"Brain"},{"key":"2449_CR182","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.3390\/jcm10194582","volume":"10","author":"T Rujeedawa","year":"2021","unstructured":"Rujeedawa T, Carrillo F\u00e9lez E, Clare ICH, Fortea J, Strydom A, Rebillat AS, Coppus A, Levin J, Zaman SH (2021) The clinical and neuropathological features of sporadic (late-onset) and genetic forms of Alzheimer's disease. J Clin Med 10:4582","journal-title":"J Clin Med"},{"key":"2449_CR183","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-180169","volume":"64","author":"A Sahoo","year":"2018","unstructured":"Sahoo A, Bejanin A, Murray ME, Tosakulwong N, Weigand SD, Serie AM, Senjem ML, Machulda MM, Parisi JE, Boeve BF, Knopman DS, Petersen RC, Dickson DW, Whitwell JL, Josephs KA (2018) TDP-43 and Alzheimer\u2019s disease pathologic subtype in non-amnestic Alzheimer\u2019s disease dementia. J Alzheimers Dis 64:1227\u20131233","journal-title":"J Alzheimers Dis"},{"key":"2449_CR184","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jalz.2019.04.011","volume":"15","author":"N Sakae","year":"2019","unstructured":"Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, van Gerpen J, Graff-Radford NR, Dickson DW (2019) Clinicopathologic subtype of Alzheimer\u2019s disease presenting as corticobasal syndrome. Alzheimers Dement 15:1218\u20131228","journal-title":"Alzheimers Dement"},{"key":"2449_CR185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000278692","volume":"29","author":"C Schmidt","year":"2010","unstructured":"Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, Roeber S, Kretzschmar H, Zerr I (2010) Clinical features of rapidly progressive Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 29:371\u2013378","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2449_CR186","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","volume":"68","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I (2011) Rapidly progressive Alzheimer disease. Arch Neurol 68:1124\u20131130","journal-title":"Arch Neurol"},{"key":"2449_CR187","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","volume":"30","author":"C Schmidt","year":"2012","unstructured":"Schmidt C, Haik S, Satoh K, Rabano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I (2012) Rapidly progressive Alzheimer\u2019s disease: a multicenter update. J Alzheimers Dis 30:751\u2013756","journal-title":"J Alzheimers Dis"},{"key":"2449_CR188","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W, Bennett DA (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197\u20132204","journal-title":"Neurology"},{"key":"2449_CR189","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2021.11768","volume":"326","author":"KA Schulman","year":"2021","unstructured":"Schulman KA, Greicius MD, Richman B (2021) Will CMS find aducanumab reasonable and necessary for Alzheimer disease after FDA approval? JAMA 326:383\u2013384","journal-title":"JAMA"},{"key":"2449_CR190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00401-020-02249-0","volume":"141","author":"D Sepulveda-Falla","year":"2021","unstructured":"Sepulveda-Falla D, Chavez-Gutierrez L, Portelius E, V\u00e9lez JI, Dujardin S, Barrera-Ocampo A, Dinkel F, Hagel C, Puig B, Mastronardi C, Lopera F, Hyman BT, Blennow K, Arcos-Burgos M, de Strooper B, Glatzel M (2021) A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer\u2019s disease. Acta Neuropathol 141:217\u2013233","journal-title":"Acta Neuropathol"},{"key":"2449_CR191","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-021-00422-x","volume":"16","author":"M Shafiq","year":"2021","unstructured":"Shafiq M, Zafar S, Younas N, Noor A, Puig B, Altmeppen HC, Schmitz M, Matschke J, Ferrer I, Glatzel M, Zerr I (2021) Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer\u2019s disease. Mol Neurodegener 16:11","journal-title":"Mol Neurodegener"},{"key":"2449_CR192","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuroimage.2006.06.010","volume":"33","author":"A Shiino","year":"2006","unstructured":"Shiino A, Watanabe T, Maeda K, Kotani E, Akiguchi I, Matsuda M (2006) Four subgroups of Alzheimer\u2019s disease based on patterns of atrophy using VBM and a unique pattern for early onset disease. Neuroimage 33:17\u201326","journal-title":"Neuroimage"},{"key":"2449_CR193","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13195-019-0541-9","volume":"11","author":"WS Shin","year":"2019","unstructured":"Shin WS, Di J, Cao Q, Li B, Seidler PM, Murray KA, Bitan G, Jiang L (2019) Amyloid beta-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimers Res Ther 11:86","journal-title":"Alzheimers Res Ther"},{"key":"2449_CR194","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2990.2009.01038.x","volume":"35","author":"G Simic","year":"2009","unstructured":"Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR (2009) Does Alzheimer\u2019s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532\u2013554","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2449_CR195","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jnnp-2020-325497","volume":"92","author":"E Singleton","year":"2021","unstructured":"Singleton E, Hansson O, Pijnenburg YAL, La Joie R, Mantyh WG, Tideman P, Stomrud E, Leuzy A, Johansson M, Strandberg O, Smith R, Berendrecht E, Miller BL, Iaccarino L, Edwards L, Strom A, Wolters EE, Coomans E, Visser D, Golla SSV, Tuncel H, Bouwman F, Van Swieten JC, Papma JM, van Berckel B, Scheltens P, Dijkstra AA, Rabinovici GD, Ossenkoppele R (2021) Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 92:872\u2013880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2449_CR196","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awaa155","volume":"143","author":"I Sintini","year":"2020","unstructured":"Sintini I, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Martin PR, Jones DT, Boeve BF, Knopman DS, Kantarci K, Petersen RC, Jack CR, Lowe VJ, Josephs KA, Whitwell JL (2020) Longitudinal neuroimaging biomarkers differ across Alzheimer\u2019s disease phenotypes. Brain 143:2281\u20132294","journal-title":"Brain"},{"key":"2449_CR197","doi-asserted-by":"crossref","first-page":"e2272","DOI":"10.1212\/WNL.0000000000011772","volume":"96","author":"DS Smirnov","year":"2021","unstructured":"Smirnov DS, Galasko D, Hiniker A, Edland SD, Salmon DP (2021) Age-at-onset and APOE-related heterogeneity in pathologically confirmed sporadic Alzheimer disease. Neurology 96:e2272\u2013e2283","journal-title":"Neurology"},{"key":"2449_CR198","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/ijms22052780","volume":"22","author":"S Sorrentino","year":"2021","unstructured":"Sorrentino S, Ascari R, Maderna E, Catania M, Ghetti B, Tagliavini F, Giaccone G, Di Fede G (2021) Microglial heterogeneity and its potential role in driving phenotypic diversity of Alzheimer\u2019s disease. Int J Mol Sci 22:2780","journal-title":"Int J Mol Sci"},{"key":"2449_CR199","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, Hepker M, Hwang JH, Miller ZA, Huang EJ, Karydas AM, Grant H, Boxer AL, Gorno-Tempini ML, Rosen HJ, Kramer JH, Miller BL, Seeley WW, Rabinovici GD, Grinberg LT (2021) Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain 144:2186\u20132198","journal-title":"Brain"},{"key":"2449_CR200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.24885","volume":"81","author":"EG Spinelli","year":"2017","unstructured":"Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F, Grinberg LT, Huang EJ, Trojanowski JQ, Meyer M, Henry ML, Comi G, Rabinovici G, Rosen HJ, Filippi M, Miller BL, Seeley WW, Gorno-Tempini ML (2017) Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 81:430\u2013443","journal-title":"Ann Neurol"},{"key":"2449_CR201","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y (2012) Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol 11:1006\u20131012","journal-title":"Lancet Neurol"},{"key":"2449_CR202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s40478-021-01255-x","volume":"9","author":"BE Stopschinski","year":"2021","unstructured":"Stopschinski BE, Del Tredici K, Estill-Terpack SJ, Ghebremdehin E, Yu FF, Braak H, Diamond MI (2021) Anatomic survey of seeding in Alzheimer\u2019s disease brains reveals unexpected patterns. Acta Neuropathol Commun 9:164","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3233\/JAD-201032","volume":"79","author":"SJ Teipel","year":"2021","unstructured":"Teipel SJ, Temp AGM, Levin F, Dyrba M, Grothe MJ (2021) Association of TDP-43 pathology with global and regional 18F-florbetapir PET signal in the Alzheimer\u2019s disease spectrum. J Alzheimers Dis 79:663\u2013670","journal-title":"J Alzheimers Dis"},{"key":"2449_CR204","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/brain\/awy264","volume":"141","author":"M ten Kate","year":"2018","unstructured":"Ten Kate M, Dicks E, Visser PJ, van der Flier WM, Teunissen CE, Barkhof F, Scheltens P, Tijms BM (2018) Atrophy subtypes in prodromal Alzheimer\u2019s disease are associated with cognitive decline. Brain 141:3443\u20133456","journal-title":"Brain"},{"key":"2449_CR205","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3233\/JAD-170740","volume":"62","author":"KA Tetzloff","year":"2018","unstructured":"Tetzloff KA, Graff-Radford J, Martin PR, Tosakulwong N, Machulda MM, Duffy JR, Clark HM, Senjem ML, Schwarz CG, Spychalla AJ, Drubach DA, Jack CR, Lowe VJ, Josephs KA, Whitwell JL (2018) Regional distribution, asymmetry, and clinical correlates of tau uptake on [18F]AV-1451 PET in atypical Alzheimer\u2019s disease. J Alzheimers Dis 62:1713\u20131724","journal-title":"J Alzheimers Dis"},{"key":"2449_CR206","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41374-019-0186-0","volume":"99","author":"M Teylan","year":"2019","unstructured":"Teylan M, Besser LM, Crary JF, Mock C, Gauthreaux K, Thomas NM, Chen YC, Kukull WA (2019) Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer\u2019s neuropathology. Lab Investig 99:1049\u20131055","journal-title":"Lab Investig"},{"key":"2449_CR207","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"2449_CR208","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1038\/s41598-020-71305-2","volume":"10","author":"DX Thomas","year":"2020","unstructured":"Thomas DX, Bajaj S, McRae-McKee K, Hadjichrysanthou C, Anderson RM, Collinge J (2020) Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer\u2019s disease neuropathology. Sci Rep 10:14579","journal-title":"Sci Rep"},{"key":"2449_CR209","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/proteomes9030036","volume":"9","author":"BM Tijms","year":"2021","unstructured":"Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lle\u00f3 A, Molinu\u00e9vo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, Lovestone S, Streffer J, Vos S, ADNI, Blennow K, Scheltens P, Zetterberg H, Visser PJ (2021) CSF proteomic Alzheimer\u2019s disease-predictive subtypes in cognitively intact amyloid negative individuals. Proteomes 9:36","journal-title":"Proteomes"},{"key":"2449_CR210","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/01.WNL.0000118212.41542.E7","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Alzheimer disease without neocortical neurofibrillary tangles: \u201ca second look.\u201d Neurology 62:1141\u20131147","journal-title":"Neurology"},{"key":"2449_CR211","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1750-3639.2002.tb00421.x","volume":"12","author":"T Togo","year":"2002","unstructured":"Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45\u201352","journal-title":"Brain Pathol"},{"key":"2449_CR212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-020-00934-5","volume":"8","author":"SO Tom\u00e9","year":"2020","unstructured":"Tom\u00e9 SO, Vandenberghe R, Ospitalieri S, Van Schoor E, Tousseyn T, Otto M, von Arnim CAF, Thal DR (2020) Distinct molecular patterns of TDP-43 pathology in Alzheimer\u2019s disease: relationship with clinical phenotypes. Acta Neuropathol Commun 8:61","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR213","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ane.12415","volume":"132","author":"G Tosto","year":"2015","unstructured":"Tosto G, Gasparini M, Brickman AM, Letteri F, Renie R, Piscopo P, Talarico G, Canevelli M, Confaloni A, Bruno G (2015) Neuropsychological predictors of rapidly progressive Alzheimer\u2019s disease. Acta Neurol Scand 132:417\u2013422","journal-title":"Acta Neurol Scand"},{"key":"2449_CR214","doi-asserted-by":"crossref","first-page":"fcaa068","DOI":"10.1093\/braincomms\/fcaa068","volume":"2","author":"RA Townley","year":"2020","unstructured":"Townley RA, Graff-Radford J, Mantyh WG, Botha H, Polsinelli AJ, Przybelski SA, Machulda MM, Makhlouf AT, Senjem ML, Murray ME, Reichard RR, Savica R, Boeve BF, Drubach DA, Josephs KA, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Jones DT (2020) Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes. Brain Commun 2:fcaa068","journal-title":"Brain Commun"},{"key":"2449_CR215","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01146-y","author":"JA Trejo-Lopez","year":"2021","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S (2021) Neuropathology of Alzheimer's disease. Neurotherapeutics. https:\/\/doi.org\/10.1007\/s13311-021-01146-y","journal-title":"Neurotherapeutics"},{"key":"2449_CR216","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10689-1","author":"H Ulugut","year":"2021","unstructured":"Ulugut H, Stek S, Wagemans LEE, Jutten RJ, Keulen MA, Bouwman FH, Prins ND, Lemstra AW, Krudop W, Teunissen CE, van Berckel BNM, Ossenkoppele R, Barkhof F, van der Flier WM, Scheltens P, Pijnenburg YAL (2021) The natural history of primary progressive aphasia: beyond aphasia. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10689-1","journal-title":"J Neurol"},{"key":"2449_CR217","doi-asserted-by":"crossref","first-page":"e12201","DOI":"10.1002\/trc2.12201","volume":"7","author":"M Uretsky","year":"2021","unstructured":"Uretsky M, Gibbons LE, Mukherjee S, Trittschuh EH, Fardo DW, Boyle PA, Keene CD, Saykin AJ, Crane PK, Schneider JA, Mez J (2021) Longitudinal cognitive performance of Alzheimer\u2019s disease neuropathological subtypes. Alzheimers Dement (n y) 7:e12201","journal-title":"Alzheimers Dement (n y)"},{"key":"2449_CR218","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1212\/WNL.0000000000007821","volume":"93","author":"AC van Loenhoud","year":"2019","unstructured":"van Loenhoud AC, van der Flier WM, Wink AM, Dicks E, Groot C, Twisk J, Barkhof F, Scheltens P, Ossenkoppele R (2019) Cognitive reserve and clinical progression in Alzheimer disease: a paradoxical relationship. Neurology 93:e334\u2013e346","journal-title":"Neurology"},{"key":"2449_CR219","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","volume":"142","author":"J Vaquer-Alicea","year":"2021","unstructured":"Vaquer-Alicea J, Diamond MI, Joachimiak LA (2021) Tau strains shape disease. Acta Neuropathol 142:57\u201371","journal-title":"Acta Neuropathol"},{"key":"2449_CR220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neuroimage.2016.02.041","volume":"145","author":"E Varol","year":"2017","unstructured":"Varol E, Sotiras A, Davatzikos C (2017) HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework. Neuroimage 145:346\u2013364","journal-title":"Neuroimage"},{"key":"2449_CR221","doi-asserted-by":"crossref","first-page":"750665","DOI":"10.3389\/fimmu.2021.750665","volume":"12","author":"E Vel\u00e1squez","year":"2021","unstructured":"Vel\u00e1squez E, Szeitz B, Gil J, Rodriguez J, Palkovits M, Renner \u00c9, Hortob\u00e1gyi T, D\u00f6me P, Nogueira FC, Marko-Varga G, Domont GB, Rezeli M (2021) Topological dissection of proteomic changes linked to the limbic stage of Alzheimer\u2019s disease. Front Immunol 12:750665","journal-title":"Front Immunol"},{"key":"2449_CR222","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-018-1953-5","volume":"137","author":"C Vergara","year":"2019","unstructured":"Vergara C, Houben S, Suain V, Yilmaz Z, De Decker R, Vanden Dries V, Boom A, Mansour S, Leroy K, Ando K, Brion JP (2019) Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol 137:397\u2013412","journal-title":"Acta Neuropathol"},{"key":"2449_CR223","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin \u00c5K, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ (2019) Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype. Alzheimers Dement 15:888\u2013898","journal-title":"Alzheimers Dement"},{"key":"2449_CR224","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0039-1681041","volume":"39","author":"N Villain","year":"2019","unstructured":"Villain N, Dubois B (2019) Alzheimer's disease including focal presentations. Semin Neurol 39:213\u2013226","journal-title":"Semin Neurol"},{"key":"2449_CR225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, La Joie R, Aksman LM, Grothe MJ, Iturria-Medina Y, Pontecorvo MJ, Devous MD, Rabinovici GD, Alexander DC, Lyoo CH, Evans AC, Hansson O (2021) Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med 27:871\u2013881","journal-title":"Nat Med"},{"key":"2449_CR226","first-page":"31","volume":"1","author":"LC Walker","year":"2020","unstructured":"Walker LC (2020) A\u00df Plaques Free Neuropathol 1:31","journal-title":"A\u00df Plaques Free Neuropathol"},{"key":"2449_CR227","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jnen\/nlab032","volume":"80","author":"JM Walker","year":"2021","unstructured":"Walker JM, Fudym Y, Farrell K, Iida MA, Bieniek KF, Seshadri S, White CL, Crary JF, Richardson TE (2021a) Asymmetry of hippocampal tau pathology in primary age-related tauopathy and Alzheimer disease. J Neuropathol Exp Neurol 80:436\u2013445","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR228","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnen\/nlaa153","volume":"80","author":"JM Walker","year":"2021","unstructured":"Walker JM, Richardson TE, Farrell K, Iida MA, Foong C, Shang P, Attems J, Ayalon G, Beach TG, Bigio EH, Budson A, Cairns NJ, Corrada M, Cortes E, Dickson DW, Fischer P, Flanagan ME, Franklin E, Gearing M, Glass J, Hansen LA, Haroutunian V, Hof PR, Honig L, Kawas C, Keene CD, Kofler J, Kovacs GG, Lee EB, Lutz MI, Mao Q, Masliah E, McKee AC, McMillan CT, Mesulam MM, Murray M, Nelson PT, Perrin R, Pham T, Poon W, Purohit DP, Rissman RA, Sakai K, Sano M, Schneider JA, Stein TD, Teich AF, Trojanowski JQ, Troncoso JC, Vonsattel JP, Weintraub S, Wolk DA, Woltjer RL, Yamada M, Yu L, White CL, Crary JF (2021b) Early selective vulnerability of the CA2 hippocampal subfield in primary age-related tauopathy. J Neuropathol Exp Neurol 80:102\u2013111","journal-title":"J Neuropathol Exp Neurol"},{"key":"2449_CR229","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1017\/S0317167100015316","volume":"39","author":"BW Wang","year":"2012","unstructured":"Wang BW, Lu E, Mackenzie IR, Assaly M, Jacova C, Lee PE, Beattie BL, Hsiung GY (2012) Multiple pathologies are common in Alzheimer patients in clinical trials. Can J Neurol Sci 39:592\u2013599","journal-title":"Can J Neurol Sci"},{"key":"2449_CR230","doi-asserted-by":"crossref","first-page":"101114","DOI":"10.1016\/j.arr.2020.101114","volume":"62","author":"ZT Wang","year":"2020","unstructured":"Wang ZT, Zhang C, Wang YJ, Dong Q, Tan L, Yu JT (2020) Selective neuronal vulnerability in Alzheimer\u2019s disease. Ageing Res Rev 62:101114","journal-title":"Ageing Res Rev"},{"key":"2449_CR231","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/brain.2020.0823","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, He C, Wang Z, Zhang Z, Xie C (2021) Dynamic connectivity alteration facilitates cognitive decline in Alzheimer\u2019s disease spectrum. Brain Connect 11:213\u2013224","journal-title":"Brain Connect"},{"key":"2449_CR232","doi-asserted-by":"crossref","first-page":"fcz046","DOI":"10.1093\/braincomms\/fcz046","volume":"2","author":"AJ Weigand","year":"2020","unstructured":"Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW (2020) Is tau in the absence of amyloid on the Alzheimer\u2019s continuum?: a study of discordant PET positivity. Brain Commun 2:fcz046","journal-title":"Brain Commun"},{"key":"2449_CR233","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1212\/WNL.0000000000008666","volume":"94","author":"S Weintraub","year":"2020","unstructured":"Weintraub S, Teylan M, Rader B, Chan KCG, Bollenbeck M, Kukull WA, Coventry C, Rogalski E, Bigio E, Mesulam MM (2020) APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort. Neurology 94:e607\u2013e612","journal-title":"Neurology"},{"key":"2449_CR234","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","volume":"57","author":"KEJ Wesenhagen","year":"2020","unstructured":"Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM (2020) Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: a literature review. Crit Rev Clin Lab Sci 57:86\u201398","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2449_CR235","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.0000000000002480","volume":"86","author":"LR White","year":"2016","unstructured":"White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ (2016) Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology 86:1000\u20131008","journal-title":"Neurology"},{"key":"2449_CR236","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","volume":"11","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Jack CR Jr, Josephs KA (2012) Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: a case-control study. Lancet Neurol 11:868\u2013877","journal-title":"Lancet Neurol"},{"key":"2449_CR237","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neurobiolaging.2021.08.012","volume":"108","author":"JL Whitwell","year":"2021","unstructured":"Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Ertekin-Taner N, Machulda MM, Duffy JR, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Josephs KA (2021) Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease. Neurobiol Aging 108:90\u201398","journal-title":"Neurobiol Aging"},{"key":"2449_CR238","doi-asserted-by":"publisher","unstructured":"Wiels WA, Wittens MMJ, Zeeuws D, Baeken C, Engelborghs S (2021) Neuropsychiatric symptoms in mild cognitive impairment and dementia due to AD: relation with disease stage and cognitive deficits. Front Psychiatry 12:707580 https:\/\/doi.org\/10.3389\/fpsyt.2021.707580","DOI":"10.3389\/fpsyt.2021.707580"},{"key":"2449_CR239","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00401-019-02046-4","volume":"138","author":"VI Wiersma","year":"2019","unstructured":"Wiersma VI, van Ziel AM, Vazquez-Sanchez S, N\u00f6lle A, Berenjeno-Correa E, Bonaterra-Pastra A, Clavaguera F, Tolnay M, Musters RJP, van Weering JRT, Verhage M, Hoozemans JJM, Scheper W (2019) Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology. Acta Neuropathol 138:943\u2013970","journal-title":"Acta Neuropathol"},{"key":"2449_CR240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40478-020-00996-5","volume":"8","author":"VI Wiersma","year":"2020","unstructured":"Wiersma VI, Hoozemans JJM, Scheper W (2020) Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies. Acta Neuropathol Commun 8:153","journal-title":"Acta Neuropathol Commun"},{"key":"2449_CR241","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.pmbts.2019.08.001","volume":"168","author":"T Wisniewski","year":"2019","unstructured":"Wisniewski T, Drummond E (2019) Future horizons in Alzheimer\u2019s disease research. Prog Mol Biol Transl Sci 168:223\u2013241","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2449_CR242","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/nmt-2018-0052","volume":"9","author":"B Wong","year":"2019","unstructured":"Wong B, Lucente DE, MacLean J, Padmanabhan J, Quimby M, Brandt KD, Putcha D, Sherman J, Frosch MP, McGinnis S, Dickerson BC (2019) Diagnostic evaluation and monitoring of patients with posterior cortical atrophy. Neurodegener Dis Manag 9:217\u2013239","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"2449_CR243","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3233\/JAD-181261","volume":"70","author":"Benjamin Yi Xin Wong","year":"2019","unstructured":"Wong BYX, Yong TT, Lim L, Tan JY, Ng ASL, Ting SKS, Hameed S, Ng KP, Zhou JH, Kandiah N (2019) Medial temporal atrophy in amyloid-negative amnestic type dementia is associated with high cerebral white matter hyperintensity. J Alzheimers Dis 70:99\u2013106","journal-title":"Journal of Alzheimer's Disease"},{"key":"2449_CR244","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/ene.14321","volume":"27","author":"R Wurm","year":"2020","unstructured":"Wurm R, Klotz S, Rahimi J, Katzenschlager R, Lindeck-Pozza E, Regelsberger G, Danics K, Kapas I, B\u00edr\u00f3 ZA, St\u00f6gmann E, Gelpi E, Kovacs GG (2020) Argyrophilic grain disease in individuals younger than 75 years: clinical variability in an underrecognized limbic tauopathy. Eur J Neurol 27:1856\u20131866","journal-title":"Eur J Neurol"},{"key":"2449_CR245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","volume":"17","author":"HS Yang","year":"2018","unstructured":"Yang HS, Yu L, White CC, Chibnik LB, Chhatwal JP, Sperling RA, Bennett DA, Schneider JA, De Jager PL (2018) Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study. Lancet Neurol 17:773\u2013781","journal-title":"Lancet Neurol"},{"key":"2449_CR246","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-020-02178-y","volume":"140","author":"N Younas","year":"2020","unstructured":"Younas N, Zafar S, Shafiq M, Noor A, Siegert A, Arora AS, Galkin A, Zafar A, Schmitz M, Stadelmann C, Andreoletti O, Ferrer I, Zerr I (2020) SFPQ and tau: critical factors contributing to rapid progression of Alzheimer\u2019s disease. Acta Neuropathol 140:317\u2013339","journal-title":"Acta Neuropathol"},{"key":"2449_CR247","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JAD-170237","volume":"59","author":"S Zafar","year":"2017","unstructured":"Zafar S, Shafiq M, Younas N, Schmitz M, Ferrer I, Zerr I (2017) Prion protein interactome: identifying novel targets in slowly and rapidly progressive forms of Alzheimer\u2019s disease. J Alzheimers Dis 59:265\u2013275","journal-title":"J Alzheimers Dis"},{"key":"2449_CR248","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3233\/JAD-210719","volume":"83","author":"A Zangrossi","year":"2021","unstructured":"Zangrossi A, Montemurro S, Alto\u00e8 G, Mondini S (2021) Heterogeneity and factorial structure in Alzheimer\u2019s disease: a cognitive perspective. J Alzheimers Dis&nbsp 83:1341-1351","journal-title":"J Alzheimers Dis"},{"key":"2449_CR249","doi-asserted-by":"crossref","first-page":"E6535","DOI":"10.1073\/pnas.1611073113","volume":"113","author":"X Zhang","year":"2016","unstructured":"Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT (2016) Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 113:E6535\u2013E6544","journal-title":"Proc Natl Acad Sci USA"},{"key":"2449_CR250","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-018-0300-0","volume":"35","author":"X Zhang","year":"2019","unstructured":"Zhang X, Sun B, Wang X, Lu H, Shao F, Rozemuller AJM, Liang H, Liu C, Chen J, Huang M, Zhu K (2019) Phosphorylated TDP-43 staging of primary age-related tauopathy. Neurosci Bull 35:183\u2013192","journal-title":"Neurosci Bull"},{"key":"2449_CR251","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s12031-020-01573-0","volume":"70","author":"L Zhang","year":"2020","unstructured":"Zhang L, Jiang Y, Zhu J, Liang H, He X, Qian J, Lin H, Tao Y, Zhu K (2020) Quantitative assessment of hippocampal tau pathology in AD and PART. J Mol Neurosci 70:1808\u20131811","journal-title":"J Mol Neurosci"},{"key":"2449_CR252","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/brainsci11020278","volume":"11","author":"B Zhang","year":"2021","unstructured":"Zhang B, Lin L, Wu S, Al-Masqari Z (2021a) Multiple subtypes of Alzheimer\u2019s disease base on brain atrophy pattern. Brain Sci 11:278","journal-title":"Brain Sci"},{"key":"2449_CR253","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/brain\/awab134","volume":"144","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Aman Y, Ng CT, Chau WH, Zhang Z, Yue M, Bohm C, Jia Y, Li S, Yuan Q, Griffin J, Chiu K, Wong DSM, Wang B, Jin D, Rogaeva E, Fraser PE, Fang EF, St George-Hyslop P, Song YQ (2021b) Amyloid-beta toxicity modulates tau phosphorylation through the PAX6 signalling pathway. Brain 144:2759\u20132770","journal-title":"Brain"},{"issue":"4","key":"2449_CR254","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JAD-201274","volume":"80","author":"Baiwen Zhang","year":"2021","unstructured":"Zhang B, Lin L, Wu S (2021c) A review of brain atrophy subtypes definition and analysis for Alzheimer's disease heterogeneity studies. J Alzheimers Dis 80:1339\u20131352","journal-title":"Journal of Alzheimer's Disease"},{"key":"2449_CR255","doi-asserted-by":"crossref","first-page":"e0250278","DOI":"10.1371\/journal.pone.0250278","volume":"16","author":"C Zheng","year":"2021","unstructured":"Zheng C, Xu R (2021) Molecular subtyping of Alzheimer\u2019s disease with consensus non-negative matrix factorization. PLoS ONE 16:e0250278","journal-title":"PLoS ONE"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02449-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02449-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02449-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T06:33:02Z","timestamp":1699943582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02449-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":255,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2449"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02449-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}